Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2013 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Creating a Safe Environment in Healthcare
By Patrick M. Schmidt
Features
The Growing Scourge of Counterfeit Pharmaceuticals
By
Jim Trageser
Myths and Facts: Chronic Fatigue Syndrome
By
Ronale Tucker Rhodes, MS
Reducing the Risks of Medication Errors
By
Amy Scanlin, MS
Healthcare Reform: The Effects of the Election
By
Amy Scanlin, MS
Healthcare Workers and the Flu Vaccine: The Backlash
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
Tax and Age-Rating Restrictions May Lead to Higher Insurance Premiums
Fiscal Cliff Legislation Helps Recover Medicare Funds
HHS Grants $1.5 Billion to Fund State-Based Marketplaces
Healthcare Law Requires Pediatric Dental Coverage
HHS Relaunches Website to Help Uninsured
Reimbursement FAQs
Reimbursement FAQs: Some commonly held misunderstandings about reimbursement are clarified.
Industry News
Pancreatic Cancer Vaccine Is Promising
FDA Approves VARIZIG for Treatment of Varicella Zoster Virus in High-Risk Patients
FDA Approves Meningitis Vaccine for Children
FDA Approves Octaplas
New Study Shows Possible Improvement for CIDP Patients
Use of Immunization Info Systems Is Increasing
CDC Recommends Expanded Use of Prevnar 13 Vaccine
Autoimmune Mechanism May Cause Drug-Induced Adverse Reactions
Autoantibodies May Play Role in Alzheimer's
Vaccine May Block the Effect of Nicotine
FDA Approves First Injectable Quadrivalent Flu Vaccine
Octapharma Initiative Expands Availability of Octagam 5%
Flu Shot Also May Prevent Heart Attacks
Previous Exposure to Flu Viruses May Protect the Elderly
People and Places in the News
BioFocus
Industry Insight
The Heart of the Matter: A Flu Shot Could Save Your Life
By Keith Berman, MPH, MBA
Patient Profile
Depression: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Depression: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Recombinant and Plasma-Based Factor VIII Products Confer Similar Risks of Inhibitor Development
Subcutaneous Immunoglobulin Is a Potential Alternative to Intravenous Immunoglobulin in CIDP
Albumin Infusion Cuts Renal Impairment and Mortality Risk in Patients with Spontaneous Bacterial Peritonitis